NexGel, Inc. entered into a new Executive Employment Agreement with President and CEO Adam Levy on July 23, 2026, superseding his prior agreement that expired December 31, 2025. The contract establishes an annual base salary of $375,000 and includes discretionary cash bonuses up to $25,000 plus performance-based EBITDA targets ranging from $4 million to $8 million. Levy received a grant of options to purchase 160,000 shares at an exercise price of $0.647, with vesting scheduled for December 31, 2026, and monthly installments thereafter. The agreement provides twelve months of severance benefits upon termination without cause or for good reason, including accelerated equity vesting. NexGel, Inc. operates in the medical device industry, specializing in non-invasive therapies for pain management.